Transcripts
Gilead Sciences (GILD) earnings call transcripts
Earnings call transcripts for Gilead Sciences, Inc., with a summary, the guidance given, and what analysts pressed on.
- Q2 2026 earnings call
Management framed the quarter as broad-based commercial and clinical execution, with HIV strength raising expectations despite temporary treatment-market disruption.
Aug 04, 2026Confident0.86